Published in

The Korean Urological Association, Investigative and Clinical Urology, 6(62), p. 650, 2021

DOI: 10.4111/icu.20210097

Links

Tools

Export citation

Search in Google Scholar

Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?

Journal article published in 2021 by William John Yaxley, Rhiannon McBean ORCID, David Wong ORCID, David Grimes, Paul Vasey, Mark Frydenberg ORCID, John William Yaxley ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload
Policy details
Data provided by SHERPA/RoMEO